Report by The Patient Association in association with Danish pharmaceutical company, LEO Pharma, has highlighted a significant gap between training and support available for primary care and needs of those living with psoriasis in the UK and Ireland.
A Cancer Research UK funded study published in the British Journal of General Practice has found more than one third (34%) of patients are diagnosed with cancer as an emergency in England had not visited their GP beforehand, which is hindering their chances of achieving the best treatment outcomes. Data collected from more than 4,600
The BMA is urging politicians to take on the NHS crisis in their pre-general election manifestos. Prime Minister Theresa May announced earlier this week that there will be a snap general election in the UK on June 8th, to “secure the strong and stable leadership the country needs to see us through Brexit and beyond”.
Scotland is set to become the first UK nation to routinely offer HIV pre-exposure prophylaxis to eligible patients after the Scottish Medicines Consortium backed the use of Gilead’s Truvada along with four other new therapies to be funded by the NHS. In clinical trials Truvada (emtricitabine/tenofovir disoproxil) was revealed to cut the relative risk of
UK-based GW Pharmaceuticals’ cannabinoid Epidiolex has been awarded Orphan status by European regulators as treatment for Lennox-Gastaut Syndrome (LGS), a rare and severe form of childhood-onset epilepsy. The approval follows data from two late-stage trials that showed when Epidiolex was added as an adjunct to patients’ current treatment, there was a significant reduction in the
NHS England has announced a review that could lead prescriptions deemed to be low value such as sun cream and gluten-free foods could soon be unavailable on the NHS in England. The plan follows extensive work by NHS Clinical Commissioners, who identified significant areas where savings of up to £400 million per year could
Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by antibiotic resistant bacteria. The Pfizer drug is a fixed combination of avibactam, a new beta-lactamase inhibitor, and ceftazidime, an antibiotic belonging to the class of third generation cephalosporins which is already approved for use in the EU.
Researchers at the Universities of Dundee and Edinburgh in Scotland will be working with the pharmaceutical industry to improve understanding of the biological processes that could form the basis of new therapies to support tissue regeneration or repair. The National Phenotypic Screening Centre (NPSC) at the University of Dundee and the Medical Research Council Centre
NHS England announces three new specialised treatments are to be made available on the NHS for patients in England after initial rejection for funding back in December. Funding has been now been approved for second allogeneic haematopoietic stem cell transplants (also known as bone marrow transplants), with around 15 patients a year who suffer a
Figures published by NHS Improvement shows that NHS provider sector has generated a year-to-date deficit of £886 million, with the sector forecasting a year-end deficit of £873m. According to the regulator, NHS providers are “experiencing one of the most challenging winters on record” due to a huge increase in the demand for urgent and emergency